[1]
C. Faria, D. Dias da Silva, e J. José Sousa, «Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making», PRPAEH, vol. 4, n.º 3, p. 12, jun. 2026.